Home › NCT06623318
IV Ensure in Patients Receiving OPAT
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Adult patients enrolled in OPAT (IV antibiotic therapy) discharged to the home setting will be included in the study. Exclusion Criteria: * Patients enrolled in OPAT (IV antibiotic therapy) discharged to nursing homes, SNF (Skilled Nursing Facility), and pediatric patients will be excluded from the study.
About the study
The purpose of remote therapeutic monitoring is to provide oversight and evaluation of patients receiving IV medications in the home setting post-acute. The goal is to improve patient outcomes and decrease re-admission rates for related diagnoses due to poor adherence. Remote therapeutic monitoring provides data used in the determination of dates, times, and duration of doses administered in the home setting to support real-time intervention by dedicated care managers to support improved adherence with prescribed dosing regiments. The objectives of the study are to:
1. Determine adherence rates for IV medications administered in the home. 2. Assess re-admission against adherence rates.
What is being tested
- Remote therapeutic monitoring device (device)
Sponsor: IV Ensure · Participants: 90 · Started: Aug 23, 2023
Contact the study team
- Mitchell T Berenson, MPH · Phone: 214-924-6951
- Jacob K Dozier, BGS · Phone: 903-244-4842
Official record on ClinicalTrials.gov — NCT06623318
Locations in the U.S.
| Oklahoma | The University of Oklahoma Health Sciences Center, Oklahoma City |
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.